Lukas Biomedical Inc. (TPEX:6814)
Taiwan · Delayed Price · Currency is TWD 18.50
0.00 (0.00%)
Oct 8, 2026, 2:59 PM CST
Lukas Biomedical Market Cap
Lukas Biomedical has a market cap or net worth of 774.68 million as of October 9, 2026. It is the 35,745th most valuable company in the world and the 2,155th biggest in Taiwan. Its market cap has decreased by 34.16% in one year.
Market Cap
774.68M
Enterprise Value
996.61M
Revenue
170.01M
Global Rank
Country Rank
#2,155 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 31, 2020, Lukas Biomedical's market cap has decreased from 1.78B to 774.68M, a decrease of -56.36%. That is a compound annual growth rate of -13.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 774.68M | -40.32% |
| Dec 31, 2025 | 1.30B | 3.85% |
| Dec 31, 2024 | 1.25B | 15.69% |
| Dec 29, 2023 | 1.08B | -6.98% |
| Dec 30, 2022 | 1.16B | -15.47% |
| Dec 30, 2021 | 1.37B | -22.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TCI GENE | 968.38M |
| Meribank Biotech | 953.04M |
| MegaPro Biomedical | 893.15M |
| NatureWise Biotech & Medicals | 809.22M |
| BioLASCO Taiwan | 729.94M |
| Neith | 703.95M |
| Taiwan Advance Bio-Pharmaceutical | 679.50M |
| Enimmune | 658.00M |